Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA

Medicare Prescription Drug Benefit

 

Training Aid: Medicare Part D 101 PowerPoint Presentation

This slide set is intended for use in training on the Medicare Part D prescription drug benefit and its implications for HIV/AIDS programs.  This 20-30 minute presentation can be downloaded in PowerPoint 300 KB (includes Talking Points for trainers to use in presenting the material) or PDF 305KB.
Slide 1: Medicare Part D Drug Benefit and HIV Care
  Mary R. Vienna
Deputy Director, HRSA/HAB/DTTA
Rockville, Maryland
  Talking points: This presentation was prepared by HRSA's HIV/AIDS Bureau (HRSA/HAB) and is intended to explain the Medicare prescription drug benefit (Part D) and its implementation, with a focus on implications for HIV/AIDS care.
 
Slide 2: Medicare 101 Topics Covered
  Medicare prescription drug program
  • Benefit structure
  • Low income subsidies
  • Formulary requirements
  • Implications for those on both Medicare and Medicaid
  • Role of the AIDS Drug Assistance Program
  • Cost sharing information for 2007
Slides cover only the basics
 
Slide 3: Medicaid versus Medicare
 

 

Medicaid

Medicare

Structure

Federal and State program with State flexibility

Federal program

Means Test

Yes - takes into account financial resources

No

Eligibility

Poor AND

  • Disabled on Supplemental Security Income (SSI)
  • Parents, children, pregnant women
  • Medically Needy

65 or older OR

Permanently disabled (under 65 and receiving Social Security Disability Income (SSDI) for 2 years)

Eligible with HIV/AIDS

266,247 with HIV/AIDS (about 50% of those in care)

Approx 100,000 with HIV/AIDS (25% of those in care); more likely to have AIDS diagnosis and CD4 count 0-199*

 * CMS estimates, March 2006

  Talking Points: Talking Points: To understand Part D probably requires some background information about the largest public health insurance programs: Medicaid and Medicare, the latter of which is where Part D resides. People living with HIV disease (PLWH) are unusually reliant on Medicaid and Medicare for their health insurance coverage. Fifty percent of all PLWH are covered by either Medicaid, Medicare, or a combination of the two. Most individuals with HIV/AIDS qualify for Medicare or Medicaid by being disabled due to AIDS. Medicaid is a health insurance program paid for by federal and state funds. It is for people with low income AND disabled, children, pregnant women, and families. Medicaid is administered by state Medicaid agencies and the Centers for Medicare and Medicaid Services (CMS). Medicaid eligibility is determined by income status and one of the following: disabled and on Supplemental Security Income (SSI - payments to the blind, aged, and disabled individuals who are low income); pregnant women, children and teenagers, or medically needy (which is a state option under Medicaid where medical expenses can be subtracted from the individual's income to qualify them for Medicaid (a process called spend-down)). Medicare is a federal entitlement program for the aged and disabled. It is administered by CMS. Prior to Part D, there was no prescription drug coverage under Medicare. Medicare eligibility is determined by being 65 or older or being on Social Security Disability Income (SSDI) for 24 months. SSDI is a benefit for those who cannot work due to disability and have acquired a sufficient number of work credits to qualify for Social Security payments.
 
Slide 4: Medicare and HIV/AIDS
  There are about 100,000Medicare beneficiaries with HIV/AIDS
  • Most qualify by being on Social Security Disability Income (SSDI) for
    2+ years
  • 70% of Medicare eligible PLWH (60,000-70,000) also qualify for Medicaid and are called  
  • dually eligible'
  Talking Points: The Medicare Modernization Act (MMA) (Part D) gives prescription drug coverage to an estimated 100,000 people living with HIV/AIDS (PLWH/A) who are receiving Medicare benefits, along with roughly 42 million other Medicare beneficiaries. PLWH/A on Medicare qualify primarily due to their disability status in terms of being on Social Security Disability Income (SSDI) for 2+ years. The majority of Medicare eligible PLWH/A, about 70%, also qualify for Medicaid. The term dually eligible is a Medicare beneficiary who also qualifies for Medicaid.
 
Slide 5:Medicare Modernization Act (MMA)
  Addeda prescription drug benefit to Medicare, known as Medicare Part D
  • Most Medicare beneficiaries must elect the benefit and choose a plan
  • Dual eligible beneficiaries areautomatically enrolled in Medicare Part D plans because prescription drug coverage switched from Medicaid to Medicare
  Talking Points: The Medicare Prescription Drug, Improvement and Modernization Act (MMA) of 2003 was signed into law on December 8, 2003.  It is the biggest change to Medicare in 40 years.  The benefit started January 1, 2006. It added a prescription drug benefit to Medicare called Medicare Part D. Dual eligible beneficiaries were automatically enrolled in Medicare Part D plans because prescription drug coverage switched from Medicaid to Medicare January 1, 2006.  A key feature of Part D plans is that formularies (meaning the list of drugs that are covered under a plan) must include all antiretroviral, antidepressant, antipsychotic, anticonvulsant, antineoplastic and immunosuppressant drugs.
 
Slide 6: Basic Prescription Drug Benefit Scenarios
 
  • " Benefit will differ depending on beneficiary's residence
  • " Benefit requires coordination with the Centers for Medicare and Medicaid Services (CMS), the Social Security Agency (SSA) and State Medicaid Agencies to ensure people are enrolled in Part D and get extra help
  • " Medicare is not the primary payer
  • " Actual plans offered will vary from standard plan structure but must be actuarially equivalent
  Talking Points: Because the Medicare Part D benefit varies depending on the beneficiary's residence, coordination among programs is essential and includes CMS, the Social Security Administration and State Medicaid Agencies to ensure that individuals are enrolled in Part D and get the assistance they qualify for.
When it comes to looking at an individual who relies on other sources of payment for drug costs, keep in mind that Medicare is considered as the secondary payer. This means that other sources must pay first, before Medicare does. This requires coordination with other drug plans/payers.
The prescription drug plans offered under Part D also varies by state/location. This is because the private companies offering plans have flexibility in designing the benefits, subject to certain constraints such as an actuarially equivalent standard (the overall cost of the plan's benefit must be equal to the standard model), in establishing the structure of their plans.
 
Slide7: Part D Drug Benefit Varies
 
  • " Differences exist in the Part D benefit received by Medicare beneficiaries depending on their Medicaid status, income and assets
  • " Variance due to low income subsidies (known as "extra help") that Medicare pays to the plan the person is enrolled in
  • " Four types of benefits
    • Full subsidy dual eligible <100% FPL
    • Full subsidy
    • Partial subsidy
    • Standard benefit
  • Drugs cost $1,300 per month
  • Jane pays $6 in co-pays per month for two scripts (income < 100% FPL so $3 brand name co-pay applies) for three months
  • By 4 th month, total drug costs of $5,200 exceeds $5,100 catastrophic coverage level ($1,300 x 4)
  • No cost to Jane after that
  • Jane pays $18 for the year [3 months of $6 co-pay]
  Talking Points: Slide seven illustrates this top bar on Slide 6 in more detail. This is a case study of a hypothetical person named Jane Matthews. She's on Social Security disability and she's dually eligible. For purposes of comparison, she's receiving a disability income benefit of $780 per month, which is less than 100 percent of the federal poverty level. And she's on an (antiretroviral) regimen of (Sustiva) and (Truvada), which has a cost of approximately $1,300 per month. So to play out the Medicare benefit as Jane experiences it, she would pay $6 in co-pays per month for two brand name prescriptions. And by the fourth month, her total drug costs of $5,200 exceed the $5,100 level. And so she doesn't pay any co-pays after that. And so her total costs for the year are $18.
 
Slide 8: Low-Income Subsidies
 
  • " Most Medicare beneficiaries with HIV/AIDS will qualify for some type of low-income subsidy
  • " Dual eligibles, Medicare beneficiaries on Supplemental Security Income (SSI) or in a Medicare Savings Program (QMB, SLMB, QI) are automatically eligible
  • " Beneficiaries who aren't included in the group above but meet income and asset criteria need to apply to Social Security or Medicaid to qualify for a subsidy
  • " Subsidy counts toward out-of-pocket costs and reaching catastrophic coverage level
  Talking Points: Low Income Subsidies that help individuals pay for Part D costs are called extra help. Most Medicare beneficiaries with HIV/AIDS qualify for some type of low-income subsidy. Some people with Medicare automatically qualify for this help, and they do not need to do anything to qualify. They include: (1) dually eligible, meaning they also receive full Medicaid benefits; (2) are in a Medicare Savings Program, in which they get State help with Medicare premiums and/or copayments (these programs include Qualified Medicare Beneficiaries, Specified Low- Income Medicare Beneficiaries, and Qualified Individuals); and (3) get Supplemental Security Income (SSI) benefits.
Beneficiaries who aren't included in the group above but meet income and asset criteria need to apply to Social Security or Medicaid to qualify for a subsidy. This low income subsidy counts toward out-of-pocket costs and reaching the catastrophic coverage level under the standard benefit.
 
Slide 9: Variations in Benefits, Full/Partial Subsidies, 2007
  Full subsidy dual eligibles with income ? 100% FPL*

$0 monthly premium and no deductible Slide 9
  Talking Points: These charts represent how the benefit and out-of-pocket costs apply to dual eligibles. The top chart is for full subsidy dual eligibles with income below 100% of the federal poverty level. Their copays are from $1-3.10 per drug. They have no monthly premium and no deductible to pay. The middle chart is for full subsidy eligibles. They include those with income over 100% of the federal poverty level, SSI recipients, Medicare Savings Programs Groups, and applicants with income < 135% FPL who also meet resource test. They have copays of from $2.15-5.35 per drug. Their monthly premium is $0 and they have no deductible. The bottom chart is people who qualify for some assistance but not a full subsidy. This includes applicants with income <150% FPL who also meet the resource test. They pay 85% of costs up to the out-of-pocket catastrophic cost threshold. After that point, they pay copays of $2.15-5.35 per drug.
 
Slide 10: Case Study: Jane Matthews
 
  • On SSDI, Medicare and Medicaid (dual eligible)
  • SSDI benefit $780/month (less than100% FPL)
  • Antiretroviral regimen is Sustiva + Truvada
  • Drugs cost $1,200 per month
  • Jane pays $6.20 in co-pays per month for two scripts (income < 100% FPL so $3.10 brand name co-pay applies) for four months
  • By 5th month, total drug costs of $6,000 exceed $5,451.25 catastrophic coverage level ($1,200 x 5)
  • No cost to Jane after that
  • Jane pays $24.80 for the year [4 months of $6.20 co-pay]
  Talking Points: On the bottom bar on slide 10, which is the same slide as six and eight (we're just repeating them here for clarity), this illustrates what's called the partial low income subsidy or partial extra help. Everyone in this group has to apply for extra help to get this benefit. This applies to Medicare eligibles with an income less than 150 percent of the federal poverty limit who meet a different asset test that's a little bit higher than the others. These individuals, if you're reading from the left to the right, pay a $50 deductible. And then up until $5,100 worth of drug costs, they pay 15 percent co-insurance for their drug. Once they reach that $5,100 limit, then they pay $2 generic, $5 brand name co-pay for the rest of their drugs for the year.
 
Slide 11: Case Study: Jason Smith
  Full subsidy – this includes:
  • Dual eligibles with income >100% FPL
  • SSI Recipients
  • Medicare Savings Programs Groups
  • Applicants with income < 135% FPL who also meet resource test

Slide 11

  Talking Points: This bar chart shows the full subsidy category. This includes a dual eligible with income above 100% FPL and those who qualify for the full low-income subsidy because they are deemed eligible or apply and qualify by income and asset level (includes SSI Recipients, Medicare Savings Programs Groups, applicants with income < 135% FPL who also meet resource test). People in this category have no monthly premium and no deductible. Their per drug copays are $2.15-$5.35 per drug.
 
Slides 12: Case Study #2: Joseph Black Full Subsidy >100% FPL
 
  • On SSDI and Medicare
  • SSDI benefit is $950/month (less than120% FPL)
  • Antiretroviral regimen is Sustiva + Truvada
  • Drugs cost $1,200 per month
  • Joseph pays $10.70 in co-pays per month for two scripts ($5.35 brand name co-pay times two) for four months
  • By th month, total drug costs of $6,00 exceed $5,451.25 catastrophic coverage level ($1,200 x 5)
  • No cost to Joseph after that
  • Joseph pays $42.80 for the year [4 months of $10.70 co-pay]
  Talking Points: Let’s examine a case study of an individual who falls in the description on the full low income subsidy.  This person is on SSDI and Medicare but not on Medicaid.  Thus, he is not dual eligible and is not auto-enrolled in Part D.  He applies to SSA and because his income is under 130% of FPL, and he meets the individual asset test, he qualifies for the full LIS.  For purposes of comparison, he’s on the same ARV regimen as Jane, with the same costs.  He pays $32.10 for the year.  These costs could be decreased if his doctor wrote him 60 or 90 day scripts instead of monthly scripts. 
 
Slide 13: Variation in Benefits, Partial Subsidy, 2007
  Partial subsidy: applicants with income <150% FPL who also meet the resource test
Slide 13
  Talking Points:

This category is people who qualify for some assistance but not a full low income subsidy.  This includes applicants with income <150% FPL who also meet resource test.  They pay 85% of costs up to the catastrophic drug coverage level, after which they pay copays of $2.15-5.35 per drug.

 
Slide 14: Case Study #3: Jason Smith, Partial Subsidy
 
  • On SSDI, Medicare and small private disability insurance benefit
  • Income $1,100 per month (138% FPL)
  • Antiviral regimen is Sustiva + Truvada
  • Drugs cost $1,200 per month
  • Jason pays:

o        Month 1: $225.05: $53 deductible plus $172.05 (15% coinsurance of $1,147 balance [$1,200 - $53 = $1147])

o        Month 2: $180: 15% coinsurance of $1,200

o        Month 3: $180:  15% coinsurance of $1,200

o        Month 4: $180:  15% coinsurance of $1,200 (total drug costs are $4,800)

o        Month 5: $97.69:  15% coinsurance on $651.25 balance to bring total drug costs to catastrophic coverage level of  $5451.25 [$4,800 + 651.25 = $5461.25]

o        Months 6-12: $10.70 per month ($5.35 brand name co-pays times two)

  • Jason pays $1,033.64 for the year [$96 in premiums, $862.74 in deductible and coinsurance, $74.90 in co-pays]
  Talking Points: This scenario is for an individual eligible for a partial low income subsidy.  Jason Smith is someone on SSDI income and a private disability insurance benefit.  His income is 138% of FPL and he meets the asset limit requirements for Part D.  He applies to SSA for a LIS and is qualified for a partial LIS.

For purposes of comparison with Jane and Joseph, Jason is on the same ARV regimen at the same cost.  Because Jason’s income is at 138% of FPL, he qualifies for a 75% premium subsidy and thus only has to pay 25% of the $32 monthly premium cost.  This comes to $8 per month in premiums.  In month one, he pays $255.05, which includes the $53 deductible + $202.05 (15% co-insurance of the $1,347 balance). 

By month 4, he has reached the catastrophic drug coverage level in drug costs.  Thus, at no time is Jason in the “donut hole.”

 
Slide 15: Sliding Scale Premium Assistance
 
FPL & Assets % of Premium Subsidy Amount
Income at or below 135% FPL, and meet the resource test for individuals or couples
100%
Income above 135% FPL but at or below 140% FPL, and meet the resource test for individuals or couples 75%
Income above 140% FPL but at or below 145% FPL, and meet the resource test for individuals or couples
50%
Income above 145% FPL but below 150% FPL, and meet the resource test for individuals or couples
25%
  Talking Points:This is the sliding scale premium grid, meaning the monthly premium for Part D. It shows the percentage that CMS contributes as the subsidy amount toward premiums. Notice that the CMS contribution decreases in proportion as income increases.
 
Slide 16: Standard Benefit , 2007 Beneficiary Cost Excluding LIS
 
  • Monthly premium
  • $265 deductible
  • 25% coinsurance > $266 to $2,400*
  • 100% coinsurance > $2,401 to $5,451.25 (coverage gap—the “donut hole”)
  • Catastrophic coverage level: co-pay of 5% or $2.15/$5.35 (whichever is greater) after total drug costs reach $5,451.25 AND beneficiary has paid $3,850 in true out-of-pocket costs (TrOOP)

 Coinsurance is a term used in Medicare Part D that refers to the beneficiary’s contribution toward prescription drug costs until the catastrophic coverage limit has been reached

  Talking Points: For the minority of Medicare beneficiaries with HIV who are not eligible for Low Income Subsidies (LIS), what does this benefit look like?  This slide outlines their standard benefit.

In calculating TrOOP, or true out-of-pocket, monthly premiums are not counted.

 
Slide 17: Standard Benefit in 2007
  Slide 17
  Talking Points: This chart represents the standard benefit. Yellow represents what the beneficiary pays. Blue and striped areas are what the plan and/or CMS pays.
 
Slide 18: Case Study #4: Peter Jones Standard Benefit
 
  • 65 years old, HIV positive, aged into MedicareIncome $1,600 per month (200% FPL)
  • Antiretroviral regimen is Sustiva + Truvada
  • Drugs cost $1,200 per month
  • Peter pays:
    • $32 per month in premiums
    • Month 1: $265 deductible plus $233.75 (25% coinsurance on $935 balance) [$498.75]
    • Month 2: $300 coinsurance (25% of $1,200)  Drug costs have reached the $2,400 co-insurance limit) [total out-of-pocket $798.75]
    • Month 3: $1,200 prescription cost (100% coinsurance) [Peter has reached the donut hole]
    • Month 4: $1,200 cost [total out-of-pocket $3,198.75]
    • Month 5: $678.69 (100% of the balance of $651.25 to reach the catastrophic coverage level of $3,850 in out-of-pocket costs, plus $27.44, which is the 5% co-pay on the $548.75 balance of the $1,200 prescription cost [$1,200 - $651.25 = $548.75] )
    • Months 6-12: $60 per month [5% co-pay] for seven months

  • Peter pays $4,654 for the year [$384 in premiums, $3850 out-of-pocket and $420 in co-pays

  Talking Points: This case study illustrates how the benefit would play out for the consumer who does NOT qualify for a low income subsidy, or "extra help." He is called Peter Jones and has income of 200% of the federal poverty level, which means he would not qualify for LIS. In month 1, Peter would pay $548.75 towards his drugs In month 2, he would pay an additional $650; in month 3 an additional $1,400, and $1,258.69 in month 4. Toward the end of this 4 months, his cumulative TrOOP would be $3,850. He would thereafter be responsible for his 5% co-pay for the remainder of this year.
 
Slide 19: Variance in Part D Costs
Slide 19
 
Slide 20: Further Help With Costs
 
  • AIDS Drug Assistance Programs (ADAP), in accordance with State program policy, can pay:
    • Premiums
    • Deductible
    • Coinsurance (15%, 25% and 100%)
    • Co-pays
  • ADAP contributions do not count toward the $3,850 in out-of-pocket costs needed to reach the catastrophic coverage level
   
Slide 21: What Counts Toward TrOOP?
 
  • Payments made by:
    • The beneficiary
    • Another individual (e.g. family or friends)
    • Certain charities
    • A State Pharmacy Assistance Program (SPAP)
    • A personal health savings vehicle (Flexible Spending Accounts, Health Savings Accounts, and Medical Savings Accounts)
    • CMS to the plan as low income subsidies
  • Co-pays waived by a pharmacy
Slide 22: What Does NOT Count Toward TrOOP?
 
  • Premiums
  • Payments made by:
    • Group health plans (employer/retiree plans)
    • Federal government programs (e.g., Indian Health, Medicaid, Tricare, VA, Ryan White CARE Act)
    • State-run programs that are not SPAPs (e.g., Workman’s Compensation)
  • Drugs:
    • Not covered by the Medicare drug plan the person is enrolled in and not obtained through the exceptions and appeals process
    • Purchased outside the U.S.
    • Not covered under Medicare Part
Slide 23: Drugs Covered by Part D: Required
 
  • All FDA Approved Drugs with exceptions to follow
  • In order to protect against discrimination, CMS will review six drug classes in the formulary to ensure there is access to all drugs in that class:
    • Antidepressants
    • Antipsychotics
    • Anticonvulsants
    • Antiretrovirals
    • Antineoplastics
    • Immunosuppressants
  • Plans to cover all Part D drugs or use formulary
    • Part D covered versus Plan covered medications
Slide 24: Drugs NOT Covered by Part D
 
  • Part A and Part B drugs
  • Barbiturates
  • Benzodiazepines
  • Non-prescription drugs (over the counter)
  • Drugs for anorexia, weight loss or weight gain (except for cachexia due to AIDS or cancer)
  • Fertility drugs
  • Drugs for cosmetic purposes or hair growth
  • Cough and cold medication
  • Prescription vitamins and minerals, except fluoride and prenatal vitamins
Slide 25: ADAP Considerations
 
  • Medicare beneficiaries must enroll
  • ADAPs determine their role
    • Number of Medicare clients
    • Cost-neutrality
    • Extra-help vs standard benefit (donut hole)
      • Switching back to ADAP
      • Plans with no coverage gap
  • Communicating ADAP role to providers
Slide 26: Key Dates
 
  • November 15 – December 15 of each year—open enrollment period to make plan changes if any
  • If creditable coverage is lost, individual has 63 days to enroll in Medicare Part D to avoid a penalty
  • Dual eligibles will be enrolled as they become eligible

Slide 27: Web Site Resources
 
Slide 28: Contact Information
Mary R. Vienna
5600 Fishers Lane, Rm 7-29
Rockville, MD 20857
Telephone: 301/443-1380
Email: MVienna@hrsa.gov

Centers for Medicare &
Medicaid Services Links

 

Medicare Prescription Drug Coverage General Information

Medicare Prescription Drug Benefits FAQs

Medicare.gov - the Official U.S. Government site for People with Medicare


Letters from HRSA
 

December 8, 2006 Letter to Grantees

October 17, 2005 Letter to Grantees

June 14, 2005 Letter to Grantees